Express News | Alpha Tau Announces FDA Approval of Ide to Initiate Multi-Center Investigator-Initiated Study of Alpha Dart® in Immunocompromised Patients With Recurrent Cscc
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024...
Express News | Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Alpha Tau to Present at the Jefferies Global Healthcare Conference
6-K: Report of foreign private issuer (related to financial reporting)
Express News | Alpha Tau Announces Alpha Dart Treatment of First Patient With Liver Metastases of Colorectal Cancer